Famotidine and Antacids for Treatment of Dyspepsia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Famotidine and Antacids for Treatment of Dyspepsia — Stella

Home/Dyspepsia/

View on ClinicalTrials.gov

Recruiting

Back to Dyspepsia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Stony Brook University Hospital, Stony Brook, New York

Key details

Phase

Post-approval study

Sponsor

Stony Brook University

Enrollment target

~80 participants

Started

November 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.